Investigational once-weekly GLP-1 and amylin receptor agonist achieves up to 14.6% weight loss and significant blood sugar reductions
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
Donor families honoured as Apollo highlights over 27,500 transplants performed and calls for greater public participation in organ donation
The addition of the Halcyon system represents a significant milestone in the hospital’s oncology services
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries
Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices
The approval is supported by results from the Phase 3 SWOG 1826 trial
The technology enables clinicians to assess brain tissue and microvascular reperfusion directly in the angiography suite, potentially improving stroke treatment decisions and patient outcomes
The approval marks a major milestone in the global fight against antimicrobial resistance
Subscribe To Our Newsletter & Stay Updated
